The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 9, 2008, Pages 1394-1402

  Yu, Rong Bin ^a   Hong, Xin ^a   Ding, Wei Liang ^b   Tan, Yong Fei ^b   Zhang, Yong Xiang ^a   Sun, Nan Xiong ^a   Wu, Guan Ling ^a   Zhan, Sheng Wei ^c   Ge, Da Fang ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b YIXING PEOPLE S HOSPITAL   (China)

^c Maanshan Center for Disease Control and Prevention   (China)

Author keywords

Chronic infection; Genetic polymorphism; Hepatitis C virus; HLA DQA1; HLA DQB1; HLA DRB1

Indexed keywords

ALANINE AMINOTRANSFERASE; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHINESE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HAPLOTYPE; HEPATITIS C; HEREDITY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 49849103608     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05215.x     Document Type: Article

References (57)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005 5 : 558 67.
2. Thomas DL, Astemborski J, Rai RM et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000 284 : 450 6.
3. Adrian M, B. Natural history of hepatitis C: its impact on clinical management. Hepatology 2000 31 : 1014 84.
4. Sun J, Li K, Shata MT, Chan TS. The immunologic basis for hepatitis C infection. Curr. Opin. Gastroenterol. 2004 20 : 598 602.
5. Hong X, Yu RB. The mechanisms of hepatitis C virus evasion to host immune response. World Chin. J. Digestol. 2005 13 : 772 5.
6. + T lymphocytes. J. Viral Hepat. 2006 13 : 121 30.
7. + Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 2005 175 : 3603 13.
8. Yu RB, Hong X, Ding WL, Tan YF, Wu GL. Polymorphism of the HLA-DQA1 and - DQB1 genes of Han population in Jiangsu Province, China. Chin. Med. J. 2006 119 : 1930 3.
9. Shao W, Tang J, Dorak MT et al. Molecular typing of human leukocyte antigen and related polymorphisms following whole genome amplification. Tissue Antigens 2004 64 : 286 92.
10. Alric L, Fort M, Izopet J et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997 113 : 1675 81.
11. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 1998 29 : 207 13.
12. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JC, James V. Association between MHC class II alleles and clearance of circulating hepatitis C virus. J. Infect. Dis. 1998 178 : 39 44.
13. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. Lancet 1999 354 : 2119 24.
14. Vejbaesya S, Songsivilai S, Tanwandee T, Rachaibun S, Chantangpol R, Dharakul T. HLA association with hepatitis C virus infection. Hum. Immunol. 2000 61 : 348 53.
15. Alric L, Fort M, Izopet J et al. Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 2000 56 : 154 8.
16. Hong X, Yu RB, Sun NX, Wang B, Xu YC, Wu GL. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. World J. Gastroenterol. 2005 11 : 7302 7.
17. Yenigun A, Durupinar B. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection. Virology 2002 76 : 1787 9.
18. Hue S, Cacoub P, Renou C et al. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J. Infect. Dis. 2002 186 : 106 9.
19. Tillmann HL, Chen DF, Trautwein C et al. Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 2001 48 : 714 18.
20. Asti M, Martinetti M, Zavaglia C et al. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology 1999 29 : 1272 9.
21. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in Northern European Caucasoids. Hepatology 1996 24 : 1342 5.
22. Hohler T, Gerken G, Notghi A et al. MHC class II genes influence the susceptibility to chronic active hepatitis C. J. Hepatol. 1997 27 : 259 64.
23. Renou C, Halfon P, Pol S et al. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut 2002 51 : 585 90.
24. Zavaglia C, Martinetti M, Silini E et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J. Hepatol. 1998 28 : 1 7.
25. Kuzushita N, Hayashi N, Moribe T et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 1998 27 : 240 4.
26. Lopez-Vazquez A, Rodrigo L, Mina-Blanco A et al. Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J. Infect. Dis. 2004 189 : 957 63.
27. Yoshizawa K, Ota M, Saito S et al. Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease. Tissue Antigens 2003 61 : 159 65.
28. Simmonds P, McOmish F, Yap PL et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of new virus type and restriction on sequence diversity. J. Gen. Virol. 1993 74 : 661 8.
29. Puoti C, Magrini A, Stati T et al. Clinical, Histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997 26 : 1393 8.
30. Kaneshige T, Takagi K, Nakamura S, Hirasawa T, Sada M, Uchida K. Genetic analysis using fingernail DNA. Nucleic Acids Res. 1992 20 : 5489 90.
31. Dinauer DM, Luhm RA, Uzgiris AJ, Eckels DD, Hessner MJ. Sequence-based typing of HLA class II DQB1. Tissue Antigens 2000 55 : 364 8.
32. Cordovado SK, Simone AE, Mueller PW. High-resolution sequence-based typing strategy for HLA-DQA1: using SSP-PCR and subsequent genotyping analysis with novel spreadsheet program. Tissue Antigens 2001 58 : 308 14.
33. Puoti1 C, Castellacci R, Fabrizio M et al. Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC). J. Hepatol. 2002 37 : 117 23.
34. Jamal MM, Soni A, Quinn PG, Wheeler DE, Arora S, Johnston DE. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States. Hepatology 1999 30 : 1307 11.
35. Herve S, Savoyea G, Riachia G et al. Chronic hepatitis C with normal or abnormal aminotransferase levels: is it the same entity? Eur. J. Gastroenterol. Hepatol. 2001 13 : 495 500.
36. Piton A, Poynard T, Imbert-Bismut F et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology 1998 27 : 1213 9.
37. +T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels. J. Hepatol. 2002 36 : 408 16.
38. Anand BS, Velez M. Assessment of correlation between serum titers of hepatitis c virus and severity of liver disease. World J. Gastroenterol. 2004 10 : 2409 11.
39. Mathurin P, Moussalli J, Cadranel JF et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 1998 27 : 868 72.
40. Santana NP, Freitas LA, Lyra AC et al. Liver histological alteration in patients with chronic hepatitis C and normal ALT levels in city of Salvador, Northeast -Brazil. Braz. J. Infect. Dis. 2005 9 : 134 41.
41. Aikawa T, Kojima M, Onishi H et al. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J. Med. Virol. 1996 49 : 274 8.
42. Kuzushita N, Hayashi N, Katayama K et al. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. J. Med. Virol. 1996 48 : 1 7.
43. Yasunami R, Miyamoto T, Kanda T. HLA-DRB1 is related to pathological changes of the liver in chronic hepatitis C. Hepatol. Res. 1997 7 : 3 12.
44. Yoon SK, Han JY, Pyo CW et al. Association between human leukocytes antigens alleles and chronic hepatitis C virus infection in the Korean populations. Liver Int. 2005 25 : 1122 7.
45. Andrade DR Jr, Andrade DR. The influence of the human genome on chronic viral hepatitis outcome. Rev. Inst Med. Trop. Sao Paulo 2004 46 : 119 26.
46. Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis and the human genome. Hepatology 2000 31 : 819 27.
47. Donaldson PT. The interrelationship between hepatitis C virus and HLA. Eur. J. Clin. Invest. 1999 29 : 280 3.
48. Harcourt G, Hellier S, Bunce M et al. Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J. Viral Hepat. 2001 8 : 174 9.
49. Rehermann B. Interaction between the hepatitis C virus and the immune system. Semin. Liver Dis. 2000 20 : 127 41.
50. +T-cell clones. J. Virol. 2001 75 : 7803 10.
51. Yee LJ. Host genetic determinants in hepatitis C virus infection. Genes Immun. 2004 5 : 237 45.
52. Kuzushita N, Hayashi N, Kanto T et al. Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection. Gastroenterology 1999 116 : 1149 54.
53. Patel K, Norris S, Lebeck L, Feng A et al. HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology 2006 43 : 241 9.
54. Carrington M, Nelson GW, Martin MP et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999 283 (5408 1748 52.
55. Rosman AS, Waraich A, Galvin K, Casiano J, Paronetto F, Lieber CS. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am. J. Gastroenterol. 1996 91 : 498 505.
56. Inglesby TV, Rai R, Astemborski J et al. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology 1999 29 : 590 6.
57. Shakil AO, Conry-Cantilena C, Alter HJ et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann. Intern. Med. 1995 123 : 330 7.